We investigated, for the first time, to the best of our knowledge, its expression in lymphomas, showing that it is present in most tumors and that its expression is associated with PD-L1 tumor cell expression and CD8 cytotoxic T cell infiltration; this suggests a possible role of immunomodulatory treatments in PCNSLs. This evidence concerns the gene CD8A and lymphoma.